Balducci, Claudia
Orsini, Franca
Cerovic, Milica
Beeg, Marten
Rocutto, Beatrice
Dacomo, Letizia
Masone, Antonio
Busani, Eleonora
Raimondi, Ilaria
Lavigna, Giada
Chen, Po-Tao
Leva, Susanna
Colombo, Laura
Zucchelli, Chiara
Musco, Giovanna
Kanaan, Nicholas M.
Gobbi, Marco
Chiesa, Roberto
Fioriti, Luana
Forloni, Gianluigi
Funding for this research was provided by:
Italian Ministry of Health grant (RF-2021-12372337)
Alzheimer’s Association Research Fellowship (AARF-22-928286)
Fondazione Telethon (TCP15011)
National Institutes of Health grants (R01, NS082730)
Article History
Received: 23 October 2024
Accepted: 13 January 2025
First Online: 27 January 2025
Declarations
:
: The Mario Negri Institute for Pharmacological Research adheres to the principles set out in the following laws, regulation, and policies governing the Care and Use of Laboratory Animals: Italian Governing Law (D.lgs 26/2014; Authorization N°19/2008-A issued March 6, 2008 by Ministry of Health); Mario Negri Institutional Regulations and Policies providing internal authorization for persons conducting animal experiments (Quality Management System Certificate – UNI EN ISO 9001:2015 – Reg. N° 6121); the NIH Guide for the Care and Use of Laboratory Animals (2011 edition) and EU directives and guidelines (EEC Council Directive 2010/63/UE). The statement of Compliance (Assurance) with the Public Health Service (PHS) Policy on Human Care and Use of Laboratory Animals was reviewed on 9/9/2014 (Animal Welfare Assurance #A5023-01). All animals were managed in accordance with European directive 2010/63/UE and with Italian law D.l. 26/2014. The procedures were approved by the local animal-health and ethical committee and were authorized by the national authority (Istituto Superiore di Sanità; authorization numbers 370/2016-PR and 532/2021-PR). All efforts were made to reduce the number of animals by following the 3R’s rule.
: Not applicable.
: The authors declare no competing interests.